Evidence map›Paper›PMID 41841102›Full record

ArticleBioinformatics advances2026

Classification of driver and passenger mutations in different cancer types using deep neural networks.

Medha Pandey, Anoosha Paruchuri, M Michael Gromiha

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Medha PandeyDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu 600036, India.
Anoosha ParuchuriComprehensive Cancer Center, James Cancer Hospital, The Ohio State University, Columbus, OH, 43210, United States.
M Michael GromihaDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu 600036, India.ORCID https://orcid.org/0000-0002-1776-4096

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Cancer is driven by genetic changes, known as mutations, that lead to the uncontrolled division of cells. The functional significance of a vast number of these cancer somatic mutations is unknown, and it is one of the major challenges in cancer research. In this study, we performed an integrative analysis of 30 tumor types from PAN-cancer mutation data collected from the COSMIC database. We have analyzed a set of 61 364 missense mutations (57 535 drivers and 3829 passengers) from 682 cancer-causing genes and derived various important features from amino acid sequences, predicted AlphaFold structures, and amino acid contact networks. We observed that the motif-based preference, neighboring residue information, residue depth, and disorder regions around the site of mutation are important for the discrimination of drivers and passengers. Results: We further developed cancer-specific computational models to discriminate cancer-causing and passenger mutations using deep learning, and the integration of AlphaFold predicted structure information improved the pathogenicity prediction of mutations. Our method achieved an average classification accuracy of 84.06% with 10-fold cross-validation. Availability and implementation: The prediction server is available at https://web.iitm.ac.in/bioinfo2/PANDriver/index.html. We envisage that the AI-based prediction models would be an important tool to identify driver mutations and could extend the scope of precision medicine for cancer.

Identifiers

PMID41841102
PMCPMC12989160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.